New Delhi, May 2022: Iodex, the leading body pain expert from GSK Consumer Healthcare and a renowned household name in India for over 100 years, partners with Cult.fit for its rapid recovery program to support fitness enthusiasts. Through this unique collaboration, a series of videos, dedicated to the 2R’s of exercise i.e. Rest & Recovery are being rolled out exclusively for Cult.fit members.
Led by Cult.fit in-house experts, the videos will emphasize on the importance of rest and recovery post any exercise schedule. While exercise and training are important for overall fitness and health, people often tend to ignore the recovery phase. Rest and recovery are paramount as they support the body in repairing and strengthening itself in between workout sessions and more importantly allows one to recover, both physically and psychologically. By following the rapid recovery program, individuals will be able reduce the risk of injuries, increase flexibility, range of motion and improve performance.
The series is beneficial for fitness enthusiasts and athletes at different stages of their fitness journey. Iodex Rapid Action Spray is a perfect ally to not let pain stop them in their quest for achieving their dreams.
Commenting on this association, Bineet Jain, Area Marketing Lead – Pain & Respiratory Health, India Subcontinent, GSK Consumer Healthcare said, “We are happy to partner with Cult.fit for this uniquely curated Rapid Recovery program, customized for individuals with an interest in sports and exercising. As a brand that encourages individuals to stay fit and active without the worry of body pain, we are confident that this series will be highly beneficial and help with faster recovery and lay the foundation for improved physical performance day after day.”
Prachita Pujari, Cult.fit, Brand Head said, “We are looking forward to working with a brand that has such a strong legacy in pain relief and has been an essential part of Indian homes for decades. With this partnership, we are together propagating the idea and approach of efficient recovery and avoiding injuries, which is a vital part of fitness. We look forward to a fruitful association together!”
As a true body pain expert, Iodex understands pain needs of its consumers and continues to bring out innovations that cater to their evolving requirements. The brand offers an exhaustive portfolio of pain relief products including Iodex Balm, Iodex UltraGel & Iodex Rapid Action Spray, which can cater to different pain states & address varied format preferences of consumers.
More Stories
Green Energy Revolution: Mafatlal Industries Launches 4 MW Solar Power Project at Nadiad, Reinforcing Sustainability Goals
Dec 17: Mafatlal Industries Limited (MIL), the flagship of the Arvind Mafatlal Group and one of India’s oldest and most...
5 Tips for Creating a Green Image for Your Company
Re-establishing your firm as an eco-friendly brand will help it resonate with customers. Discover five tips for creating a green...
How To Manage Your Employees in a High-Turnover Industry
Many business professionals move from job to job rapidly. To combat high turnover in your industry, find out the best...
JAIN International Residential School (JIRS) Achieves Top National Rankings and Prestigious Education Awards
Bengaluru, Dec 16: JAIN International Residential School (JIRS) has been ranked No. 1 Residential School in India by the Times Education Excellence Awards 2025. The recognition reaffirms the institute's unwavering commitment to excellence...
Stanley Lifestyles Appoints Venkataramana Seshagirirao Gorti as Joint Managing Director
Bengaluru, Dec 16: Stanley Lifestyles Limited (BSE: 544202 | NSE: STANLEY), one of India’s largest integrated super-premium and luxury furniture manufacturer and retailers, today announced...
Excelsoft Technologies Reports Strong Q2 & H1 FY26 Performance Net Profit Surges 254percent YoY in H1
Mysore, Dec 16: Excelsoft Technologies Ltd., a global provider of next-generation digital learning, assessment, and education technology solutions, announced its unaudited financial results for the quarter and half year ended September 30, 2025. The key highlights...
